Stada buyout prescription finally shows results
Bain Capital and Cinven's €5.3bn buyout of German pharmaceuticals maker Stada went through this week, the firm announced on Friday, after a tense build up to Wednesday's midnight deadline, with the 63% shareholder acceptance threshold only just being reached.
Only just over 63% of shares were tendered for the deal, having been counted throughout Thursday and the final result only announced on Friday morning.
Another source close to the situation had confirmed that only around 35% of shares had been tendered by the end of last week,
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.